Target intelligence / Profile preview

Nipah virus RNA-directed RNA polymerase (NiV RdRp)

Target
NiV RdRp
Molecular classification
Enzyme, Transferase, Viral protein
01

Overview

The Nipah virus RNA-directed RNA polymerase, primarily residing within the large (L) protein, is the catalytic core of the viral replication machinery. In complex with its essential cofactor, the phosphoprotein (P), this enzyme is responsible for both the transcription of viral mRNAs and the replication of the negative-sense, single-stranded RNA genome. The L protein is a multi-domain enzyme that possesses RNA-dependent RNA polymerase (RdRp) activity, GDP polyribonucleotidyltransferase (PRNTase) activity for mRNA capping, and methyltransferase (MTase) activity for cap methylation. Because of its indispensable role in the viral life cycle and the lack of host homologs, it represents a highly attractive target for direct-acting antiviral therapeutics. Nucleoside analogs like remdesivir and favipiravir act as chain terminators or mutagens upon incorporation by the polymerase, while non-nucleoside inhibitors like ERDRP-0519 bind to allosteric pockets to block RNA synthesis. Developing effective inhibitors against this target is a high priority for epidemic preparedness due to the high fatality rate of Nipah virus infections.

Other names
Nipah virus RNA-dependent RNA polymeraseNipah virus large proteinNipah virus L proteinNipah virus RNA-directed RNA polymerase LNipah virus replicaseNipah virus transcriptase
02

Mechanism of action

Inhibition of viral RNA synthesis through chain termination, lethal mutagenesis, or allosteric disruption of the polymerase catalytic site.

03

Biological functions

Viral RNA replicationViral transcriptionmRNA cappingmRNA polyadenylation
04

Disease associations

Infection
05

Safety considerations

Emergence of drug-resistant viral mutationsOff-target toxicity of nucleoside analogsTeratogenicityNarrow therapeutic windowRapid disease progression limiting treatment window
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

Nipah virus RNA loadNipah virus antigenNipah virus antibody titer

Beyond the preview

Go deeper on Nipah virus RNA-directed RNA polymerase (NiV RdRp).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nipah virus RNA-directed RNA polymerase (NiV RdRp).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call